These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 31406349)

  • 1. Gut microbiome alteration in MORDOR I: a community-randomized trial of mass azithromycin distribution.
    Doan T; Hinterwirth A; Worden L; Arzika AM; Maliki R; Abdou A; Kane S; Zhong L; Cummings ME; Sakar S; Chen C; Cook C; Lebas E; Chow ED; Nachamkin I; Porco TC; Keenan JD; Lietman TM
    Nat Med; 2019 Sep; 25(9):1370-1376. PubMed ID: 31406349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrolide and Nonmacrolide Resistance with Mass Azithromycin Distribution.
    Doan T; Worden L; Hinterwirth A; Arzika AM; Maliki R; Abdou A; Zhong L; Chen C; Cook C; Lebas E; O'Brien KS; Oldenburg CE; Chow ED; Porco TC; Lipsitch M; Keenan JD; Lietman TM
    N Engl J Med; 2020 Nov; 383(20):1941-1950. PubMed ID: 33176084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid Reduction of
    Hinterwirth A; Sié A; Coulibaly B; Ouermi L; Dah C; Tapsoba C; Zhong L; Chen C; Lietman TM; Keenan JD; Doan T; Oldenburg CE
    Am J Trop Med Hyg; 2020 Sep; 103(3):1266-1269. PubMed ID: 32524948
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of biannual azithromycin distribution on antibody responses to malaria, bacterial, and protozoan pathogens in Niger.
    Arzika AM; Maliki R; Goodhew EB; Rogier E; Priest JW; Lebas E; O'Brien KS; Le V; Oldenburg CE; Doan T; Porco TC; Keenan JD; Lietman TM; Martin DL; Arnold BF;
    Nat Commun; 2022 Feb; 13(1):976. PubMed ID: 35190534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Mass Treatment with Azithromycin on Causes of Death in Children in Malawi: Secondary Analysis from the MORDOR Trial.
    Hart JD; Kalua K; Keenan JD; Lietman TM; Bailey RL
    Am J Trop Med Hyg; 2020 Sep; 103(3):1319-1328. PubMed ID: 32342837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biannual Treatment of Preschool Children with Single Dose Azithromycin to Reduce Mortality: Impact on Azithromycin Resistance in the MORDOR Trial in Tanzania.
    Bloch EM; Coles CL; Kasubi M; Weaver J; Mrango Z; Munoz B; Lietman TM; West SK
    Am J Trop Med Hyg; 2020 Sep; 103(3):1301-1307. PubMed ID: 32067633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut Microbial Diversity in Antibiotic-Naive Children After Systemic Antibiotic Exposure: A Randomized Controlled Trial.
    Doan T; Arzika AM; Ray KJ; Cotter SY; Kim J; Maliki R; Zhong L; Zhou Z; Porco TC; Vanderschelden B; Keenan JD; Lietman TM
    Clin Infect Dis; 2017 May; 64(9):1147-1153. PubMed ID: 28402408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-Effectiveness of Mass Treatment with Azithromycin for Reducing Child Mortality in Malawi: Secondary Analysis from the MORDOR Trial.
    Hart JD; Kalua K; Keenan JD; Lietman TM; Bailey RL
    Am J Trop Med Hyg; 2020 Sep; 103(3):1283-1290. PubMed ID: 32342840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut Microbiome Diversity and Antimicrobial Resistance After a Single Dose of Oral Azithromycin in Children: A Randomized Placebo-Controlled Trial.
    Doan T; Liu Z; Sié A; Dah C; Bountogo M; Ouattara M; Coulibaly B; Kiemde D; Zonou G; Nebie E; Brogdon J; Lebas E; Hinterwirth A; Zhong L; Chen C; Zhou Z; Porco T; Arnold BF; Oldenburg CE; Lietman TM
    Am J Trop Med Hyg; 2024 Feb; 110(2):291-294. PubMed ID: 38227963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of azithromycin mass drug administration on the antibiotic-resistant gut microbiome in children: a randomized, controlled trial.
    Pickering H; Hart JD; Burr S; Stabler R; Maleta K; Kalua K; Bailey RL; Holland MJ
    Gut Pathog; 2022 Jan; 14(1):5. PubMed ID: 34991704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Azithromycin to Reduce Childhood Mortality in Sub-Saharan Africa.
    Keenan JD; Bailey RL; West SK; Arzika AM; Hart J; Weaver J; Kalua K; Mrango Z; Ray KJ; Cook C; Lebas E; O'Brien KS; Emerson PM; Porco TC; Lietman TM;
    N Engl J Med; 2018 Apr; 378(17):1583-1592. PubMed ID: 29694816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longer-Term Assessment of Azithromycin for Reducing Childhood Mortality in Africa.
    Keenan JD; Arzika AM; Maliki R; Boubacar N; Elh Adamou S; Moussa Ali M; Cook C; Lebas E; Lin Y; Ray KJ; O'Brien KS; Doan T; Oldenburg CE; Callahan EK; Emerson PM; Porco TC; Lietman TM
    N Engl J Med; 2019 Jun; 380(23):2207-2214. PubMed ID: 31167050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cause-specific mortality of children younger than 5 years in communities receiving biannual mass azithromycin treatment in Niger: verbal autopsy results from a cluster-randomised controlled trial.
    Keenan JD; Arzika AM; Maliki R; Elh Adamou S; Ibrahim F; Kiemago M; Galo NF; Lebas E; Cook C; Vanderschelden B; Bailey RL; West SK; Porco TC; Lietman TM;
    Lancet Glob Health; 2020 Feb; 8(2):e288-e295. PubMed ID: 31981558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut Resistome of Preschool Children After Prolonged Mass Azithromycin Distribution: A Cluster-randomized Trial.
    Arzika AM; Maliki R; Abdou A; Mankara AK; Harouna AN; Cook C; Hinterwirth A; Worden L; Zhong L; Chen C; Ruder K; Zhou Z; Lebas E; O'Brien KS; Oldenburg CE; Le V; Arnold BF; Porco TC; Keenan JD; Lietman TM; Doan T
    Clin Infect Dis; 2021 Oct; 73(7):1292-1295. PubMed ID: 34037753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Causes of death after biannual azithromycin treatment: A community-level randomized clinical trial.
    Bloch EM; Mrango Z; Weaver J; Munoz B; Lietman TM; West SK
    PLoS One; 2021; 16(9):e0250197. PubMed ID: 34559801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of nasopharyngeal
    Hart JD; Samikwa L; Meleke H; Burr SE; Cornick J; Kalua K; Bailey RL
    Lancet Microbe; 2022 Feb; 3(2):e142-e150. PubMed ID: 35156069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biannual azithromycin distribution and child mortality among malnourished children: A subgroup analysis of the MORDOR cluster-randomized trial in Niger.
    O'Brien KS; Arzika AM; Maliki R; Manzo F; Mamkara AK; Lebas E; Cook C; Bailey RL; West SK; Oldenburg CE; Porco TC; Arnold B; Keenan JD; Lietman TM;
    PLoS Med; 2020 Sep; 17(9):e1003285. PubMed ID: 32931496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age-based targeting of biannual azithromycin distribution for child survival in Niger: an adaptive cluster-randomized trial protocol (AVENIR).
    O'Brien KS; Arzika AM; Amza A; Maliki R; Ousmane S; Kadri B; Nassirou B; Mankara AK; Harouna AN; Colby E; Lebas E; Liu Z; Le V; Nguyen W; Keenan JD; Oldenburg CE; Porco TC; Doan T; Arnold BF; Lietman TM;
    BMC Public Health; 2021 Apr; 21(1):822. PubMed ID: 33926403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short- and long-term impacts of azithromycin treatment on the gut microbiota in children: A double-blind, randomized, placebo-controlled trial.
    Wei S; Mortensen MS; Stokholm J; Brejnrod AD; Thorsen J; Rasmussen MA; Trivedi U; Bisgaard H; Sørensen SJ
    EBioMedicine; 2018 Dec; 38():265-272. PubMed ID: 30478001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Biannual Azithromycin Mass Drug Administration on Malaria in Malawian Children: A Cluster-Randomized Trial.
    Hart JD; Samikwa L; Sikina F; Kalua K; Keenan JD; Lietman TM; Burr SE; Bailey RL
    Am J Trop Med Hyg; 2020 Sep; 103(3):1329-1334. PubMed ID: 32342841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.